Clinical Trial Update: Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 prospective exploratory study evaluating the long-term safety and efficacy of telbivudine in Chinese patients with compensated chronic hepatitis B after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED